Combinations comprising BCRABL/C-KIT/PDGF-R TK inhibitors for treating cancer

Details for Australian Patent Application No. 2007234382 (hide)

Owner Novartis AG

Inventors Versace, Richard William; Manley, Paul W.; Linnartz, Ronald Richard; Burke, Gregory Peter

Agent Davies Collison Cave

Pub. Number AU-B-2007234382

PCT Pub. Number WO2007/115289

Priority 60/789,403 05.04.06 US

Filing date 4 April 2007

Wipo publication date 11 October 2007

Acceptance publication date 9 June 2011

International Classifications

A61K 31/454 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61K 31/573 (2006.01)

A61K 31/704 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/115289 Priority application(s): WO2007/115289

9 June 2011 Application Accepted

  Published as AU-B-2007234382

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007234388-Sacroiliac belt and composite structure

2007234380-Combination of organic compounds